How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
Ardizzone
Sandro
S
Department of Gastroenterology, L. Sacco University Hospital, Milan, Italy.
Porro
Gabriele Bianchi
GB
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D015179:Colorectal Neoplasms / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019804:Mesalamine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine